Orchard Therapeutics plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $2.38 | $0.77 | $1.57 |
| Q2 2024 | 0 | $2.03 | $0.65 | $1.34 |
| Q3 2024 | 0 | $2.33 | $0.75 | $1.54 |
Orchard Therapeutics plc Earnings Date And Information
Orchard Therapeutics plc last posted its earnings results on Monday, March 4th, 2024. The company reported $-0.6 earnings per share for the quarter, topping analysts' consensus estimates of $-2.1 by $1.5. The company had revenue of 6.30 M for the quarter and had revenue of 6.99 M for the year. Orchard Therapeutics plc has generated $-1 earnings per share over the last year ($-0.61 diluted earnings per share) and currently has a price-to-earnings ratio of 5.46. Orchard Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based on prior year's report dates.
Orchard Therapeutics plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2023 | Q3 2023 | -$1.30 | -$1.55 | -0.25 | $6.63 M | $6.30 M |
| 08/10/2023 | Q2 2023 | -$0.65 | $8.22 M | $7.31 M | ||
| 05/15/2023 | Q1 2023 | -$1.78 | -$1.23 | 0.55 | $1.24 M | |
| 03/14/2023 | Q4 2022 | $10.52 | $6.99 M | |||
| 11/14/2022 | Q3 2022 | -$2.30 | -$3.71 | -1.41 | $4.77 M | $5.78 M |
| 08/04/2022 | Q2 2022 | -$2.50 | -$3.98 | -1.48 | $3.50 M | $4.37 M |
| 05/12/2022 | Q1 2022 | -$2.50 | -$3.47 | -0.97 | $5.52 M | |
| 03/30/2022 | Q4 2021 | -$0.29 | $483,000 | |||
| 11/04/2021 | Q3 2021 | -$2.70 | -$2.86 | -0.16 | $5.10 M | $1.19 M |
| 08/04/2021 | Q2 2021 | -$3.20 | -$2.91 | 0.29 | $260,000 | $0 |
| 05/13/2021 | Q1 2021 | -$3.30 | -$3.06 | 0.24 | $0 | |
| 03/02/2021 | Q4 2020 | -$3.00 | -$3.42 | -0.42 | $2,000 | |
| 11/03/2020 | Q3 2020 | -$4.40 | -$2.04 | 2.36 | $2.81 M | $2.00 M |
| 08/06/2020 | Q2 2020 | -$4.30 | -$4.79 | -0.49 | $522,375 | $597,000 |
| 05/07/2020 | Q1 2020 | -$5.00 | -$5.12 | -0.12 | $0 | |
| 02/27/2020 | Q4 2019 | -$4.40 | -$4.62 | -0.22 | $595,000 | |
| 09/29/2019 | Q3 2019 | -$3.76 | $2.14 M | $1.92 M | ||
| 06/29/2019 | Q2 2019 | -$5.63 | $0 | |||
| 03/30/2019 | Q1 2019 | -$3.53 | $0 | |||
| 03/22/2019 | Q4 2018 | -$0.30 | $689,000 |
Orchard Therapeutics plc Earnings: Frequently Asked Questions
-
When is Orchard Therapeutics plc's earnings date?
Orchard Therapeutics plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 5th, 2024 based off last year's report dates.
-
Did Orchard Therapeutics plc beat their earnings estimates last quarter?
In the previous quarter, Orchard Therapeutics plc (:ORTX) reported $-0.6 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.1 by $1.5.
-
How can I listen to Orchard Therapeutics plc's earnings conference call?
The conference call for Orchard Therapeutics plc's latest earnings report can be listened to online.
-
How can I read Orchard Therapeutics plc's conference call transcript?
The conference call transcript for Orchard Therapeutics plc's latest earnings report can be read online.
-
How much revenue does Orchard Therapeutics plc generate each year?
Orchard Therapeutics plc (:ORTX) has a recorded annual revenue of $6.99 M.
-
How much profit does Orchard Therapeutics plc generate each year?
Orchard Therapeutics plc (:ORTX) has a recorded net income of $6.99 M. Orchard Therapeutics plc has generated $-0.61 earnings per share over the last four quarters.
-
What is Orchard Therapeutics plc's price-to-earnings ratio?
Orchard Therapeutics plc (:ORTX) has a price-to-earnings ratio of 5.46 and price/earnings-to-growth ratio is 0.07.
